-
Jay Thakkar is betting on these five sectors
Jay Thakkar, Vice-President & Head of Equity Research at Marwadi Shares and Finance, says trend in market remains quite positive in short-term
-
Chemplast Sanmar IPO opens today; key points
Chemplast Sanmar was delisted from the BSE, the NSE and MSE with effect from June 25, 2012, June 18, 2012 and June 25, 2012, respectively.
-
Here is why brokerages have ‘subscribe’ rating on Aptus Housing, despite its expensive valuations
The P/BV comes around 8.6x which makes the issue fully priced against the superlative performance leaving little to nothing for investors
-
Nirma's Nuvoco Vistas IPO: Check GMPs, brokerages' view
Nuvoco Vistas is quoting at a premium of Rs 38 or 6.67% in the grey market. Subscribe for the long-term, listing gains can be muted
-
Should you invest in CarTrade Tech IPO?
The issue looks expensively priced but being a niche company and frenzy for startup IPOs, it may accelerate in short term due to first-mover advantage
-
Continue with Glenmark Life Sciences dosage in your portfolio, despite muted listing
Glenmark Life Sciences got listed at price to earnings of 26.01x compared to Divis Lab & Laurus Lab which are trading at 65.8x & 34.2x, respectively.
-
Krsnaa Diagnostics IPO opens tomorrow
At the issue price of Rs 954, the issue looks fully priced. However, due to bullish sentiments, we may see IPO garnering good subscription.
-
Pizza Hut, Devyani International’s IPO opens tomorrow
Ahead of the IPO, shares of Devyani International are quoting at Rs 152 apiece in the grey market marking a premium of 68.89%
-
Glenmark Life IPO opens tomorrow, things you must know
Ahead of the IPO, shares of Glenmark Life Sciences were trading at Rs 855 per share marking a premium of Rs 135 or 18.75% at the upper price band
-
Zomato IPO: Stellar listing gains delivered, should you re-order?
Most analysts on the street are of the opinion that Zomato's continuous focus on unit economics and growth keeps the long-term story intact.
